Global and United States Cancer Pain Market Size, Status and Forecast 2020-2026

Global and United States Cancer Pain Market Size, Status and Forecast 2020-2026

Sep 2020 QYResearch Healthcare97 Pages Price :
$ 3900
Global Cancer Pain Scope and Market Size
Cancer Pain market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Pain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others

Market segment by Application, split into
Paracetamol Treatment-Related Immunotherapy
Radiotherapy
Chemotherapy
Hormone Therapy

Based on regional and country-level analysis, the Cancer Pain market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Cancer Pain market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
JohnsonJohnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Pain Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Opioids
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Pain Market Share by Application: 2020 VS 2026
1.3.2 Paracetamol Treatment-Related Immunotherapy
1.3.3 Radiotherapy
1.3.4 Chemotherapy
1.3.5 Hormone Therapy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Pain Market Perspective (2015-2026)
2.2 Global Cancer Pain Growth Trends by Regions
2.2.1 Cancer Pain Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Pain Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Pain Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Pain Players by Market Size
3.1.1 Global Top Cancer Pain Players by Revenue (2015-2020)
3.1.2 Global Cancer Pain Revenue Market Share by Players (2015-2020)
3.2 Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Pain Revenue
3.4 Global Cancer Pain Market Concentration Ratio
3.4.1 Global Cancer Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Pain Revenue in 2019
3.5 Key Players Cancer Pain Area Served
3.6 Key Players Cancer Pain Product Solution and Service
3.7 Date of Enter into Cancer Pain Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Pain Breakdown Data by Type (2015-2026)
4.1 Global Cancer Pain Historic Market Size by Type (2015-2020)
4.2 Global Cancer Pain Forecasted Market Size by Type (2021-2026)

5 Cancer Pain Breakdown Data by Application (2015-2026)
5.1 Global Cancer Pain Historic Market Size by Application (2015-2020)
5.2 Global Cancer Pain Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cancer Pain Market Size (2015-2026)
6.2 North America Cancer Pain Market Size by Type (2015-2020)
6.3 North America Cancer Pain Market Size by Application (2015-2020)
6.4 North America Cancer Pain Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Cancer Pain Market Size (2015-2026)
7.2 Europe Cancer Pain Market Size by Type (2015-2020)
7.3 Europe Cancer Pain Market Size by Application (2015-2020)
7.4 Europe Cancer Pain Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Cancer Pain Market Size (2015-2026)
8.2 China Cancer Pain Market Size by Type (2015-2020)
8.3 China Cancer Pain Market Size by Application (2015-2020)
8.4 China Cancer Pain Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Cancer Pain Market Size (2015-2026)
9.2 Japan Cancer Pain Market Size by Type (2015-2020)
9.3 Japan Cancer Pain Market Size by Application (2015-2020)
9.4 Japan Cancer Pain Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Cancer Pain Market Size (2015-2026)
10.2 Southeast Asia Cancer Pain Market Size by Type (2015-2020)
10.3 Southeast Asia Cancer Pain Market Size by Application (2015-2020)
10.4 Southeast Asia Cancer Pain Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 BioDelivery Science
11.1.1 BioDelivery Science Company Details
11.1.2 BioDelivery Science Business Overview
11.1.3 BioDelivery Science Cancer Pain Introduction
11.1.4 BioDelivery Science Revenue in Cancer Pain Business (2015-2020))
11.1.5 BioDelivery Science Recent Development
11.2 ProStrakan Group
11.2.1 ProStrakan Group Company Details
11.2.2 ProStrakan Group Business Overview
11.2.3 ProStrakan Group Cancer Pain Introduction
11.2.4 ProStrakan Group Revenue in Cancer Pain Business (2015-2020)
11.2.5 ProStrakan Group Recent Development
11.3 Teva pharmaceuticals
11.3.1 Teva pharmaceuticals Company Details
11.3.2 Teva pharmaceuticals Business Overview
11.3.3 Teva pharmaceuticals Cancer Pain Introduction
11.3.4 Teva pharmaceuticals Revenue in Cancer Pain Business (2015-2020)
11.3.5 Teva pharmaceuticals Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Cancer Pain Introduction
11.4.4 Eli-Lilly Revenue in Cancer Pain Business (2015-2020)
11.4.5 Eli-Lilly Recent Development
11.5 Grunenthal Group
11.5.1 Grunenthal Group Company Details
11.5.2 Grunenthal Group Business Overview
11.5.3 Grunenthal Group Cancer Pain Introduction
11.5.4 Grunenthal Group Revenue in Cancer Pain Business (2015-2020)
11.5.5 Grunenthal Group Recent Development
11.6 GW Pharmaceuticals
11.6.1 GW Pharmaceuticals Company Details
11.6.2 GW Pharmaceuticals Business Overview
11.6.3 GW Pharmaceuticals Cancer Pain Introduction
11.6.4 GW Pharmaceuticals Revenue in Cancer Pain Business (2015-2020)
11.6.5 GW Pharmaceuticals Recent Development
11.7 JohnsonJohnson
11.7.1 JohnsonJohnson Company Details
11.7.2 JohnsonJohnson Business Overview
11.7.3 JohnsonJohnson Cancer Pain Introduction
11.7.4 JohnsonJohnson Revenue in Cancer Pain Business (2015-2020)
11.7.5 JohnsonJohnson Recent Development
11.8 Meda Pharmaceuticals
11.8.1 Meda Pharmaceuticals Company Details
11.8.2 Meda Pharmaceuticals Business Overview
11.8.3 Meda Pharmaceuticals Cancer Pain Introduction
11.8.4 Meda Pharmaceuticals Revenue in Cancer Pain Business (2015-2020)
11.8.5 Meda Pharmaceuticals Recent Development
11.9 Orexo
11.9.1 Orexo Company Details
11.9.2 Orexo Business Overview
11.9.3 Orexo Cancer Pain Introduction
11.9.4 Orexo Revenue in Cancer Pain Business (2015-2020)
11.9.5 Orexo Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Cancer Pain Introduction
11.10.4 Sanofi Revenue in Cancer Pain Business (2015-2020)
11.10.5 Sanofi Recent Development
11.11 WEX Pharmaceuticals
10.11.1 WEX Pharmaceuticals Company Details
10.11.2 WEX Pharmaceuticals Business Overview
10.11.3 WEX Pharmaceuticals Cancer Pain Introduction
10.11.4 WEX Pharmaceuticals Revenue in Cancer Pain Business (2015-2020)
10.11.5 WEX Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Table

List of Tables
Table 1. Global Cancer Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Opioids
Table 4. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 5. Key Players of Others
Table 6. Global Cancer Pain Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Cancer Pain Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Cancer Pain Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Cancer Pain Market Share by Regions (2015-2020)
Table 10. Global Cancer Pain Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Cancer Pain Market Share by Regions (2021-2026)
Table 12. Cancer Pain Market Market Trends
Table 13. Cancer Pain Market Drivers
Table 14. Cancer Pain Market Challenges
Table 15. Cancer Pain Market Restraints
Table 16. Global Cancer Pain Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Cancer Pain Market Share by Players (2015-2020)
Table 18. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Pain as of 2019)
Table 19. Global Cancer Pain by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Pain Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Pain Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Cancer Pain Market Size Share by Type (2015-2020)
Table 25. Global Cancer Pain Revenue Market Share by Type (2021-2026)
Table 26. Global Cancer Pain Market Size Share by Application (2015-2020)
Table 27. Global Cancer Pain Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Cancer Pain Market Size Share by Application (2021-2026)
Table 29. North America Cancer Pain Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Cancer Pain Market Share by Type (2015-2020)
Table 31. North America Cancer Pain Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Cancer Pain Market Share by Application (2015-2020)
Table 33. North America Cancer Pain Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Cancer Pain Market Share by Country (2015-2020)
Table 35. Europe Cancer Pain Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Cancer Pain Market Share by Type (2015-2020)
Table 37. Europe Cancer Pain Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Cancer Pain Market Share by Application (2015-2020)
Table 39. Europe Cancer Pain Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Cancer Pain Market Share by Country (2015-2020)
Table 41. China Cancer Pain Market Size by Type (2015-2020) (US$ Million)
Table 42. China Cancer Pain Market Share by Type (2015-2020)
Table 43. China Cancer Pain Market Size by Application (2015-2020) (US$ Million)
Table 44. China Cancer Pain Market Share by Application (2015-2020)
Table 45. China Cancer Pain Market Size by Region (US$ Million) (2015-2020)
Table 46. China Cancer Pain Market Share by Region (2015-2020)
Table 47. Japan Cancer Pain Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Cancer Pain Market Share by Type (2015-2020)
Table 49. Japan Cancer Pain Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Cancer Pain Market Share by Application (2015-2020)
Table 51. Japan Cancer Pain Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Cancer Pain Market Share by Country (2015-2020)
Table 53. Southeast Asia Cancer Pain Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Cancer Pain Market Share by Type (2015-2020)
Table 55. Southeast Asia Cancer Pain Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Cancer Pain Market Share by Application (2015-2020)
Table 57. Southeast Asia Cancer Pain Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Cancer Pain Market Share by Country (2015-2020)
Table 59. BioDelivery Science Company Details
Table 60. BioDelivery Science Business Overview
Table 61. BioDelivery Science Product
Table 62. BioDelivery Science Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 63. BioDelivery Science Recent Development
Table 64. ProStrakan Group Company Details
Table 65. ProStrakan Group Business Overview
Table 66. ProStrakan Group Product
Table 67. ProStrakan Group Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 68. ProStrakan Group Recent Development
Table 69. Teva pharmaceuticals Company Details
Table 70. Teva pharmaceuticals Business Overview
Table 71. Teva pharmaceuticals Product
Table 72. Teva pharmaceuticals Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 73. Teva pharmaceuticals Recent Development
Table 74. Eli-Lilly Company Details
Table 75. Eli-Lilly Business Overview
Table 76. Eli-Lilly Product
Table 77. Eli-Lilly Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 78. Eli-Lilly Recent Development
Table 79. Grunenthal Group Company Details
Table 80. Grunenthal Group Business Overview
Table 81. Grunenthal Group Product
Table 82. Grunenthal Group Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 83. Grunenthal Group Recent Development
Table 84. GW Pharmaceuticals Company Details
Table 85. GW Pharmaceuticals Business Overview
Table 86. GW Pharmaceuticals Product
Table 87. GW Pharmaceuticals Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 88. GW Pharmaceuticals Recent Development
Table 89. JohnsonJohnson Company Details
Table 90. JohnsonJohnson Business Overview
Table 91. JohnsonJohnson Product
Table 92. JohnsonJohnson Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 93. JohnsonJohnson Recent Development
Table 94. Meda Pharmaceuticals Business Overview
Table 95. Meda Pharmaceuticals Product
Table 96. Meda Pharmaceuticals Company Details
Table 97. Meda Pharmaceuticals Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 98. Meda Pharmaceuticals Recent Development
Table 99. Orexo Company Details
Table 100. Orexo Business Overview
Table 101. Orexo Product
Table 102. Orexo Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 103. Orexo Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 108. Sanofi Recent Development
Table 109. WEX Pharmaceuticals Company Details
Table 110. WEX Pharmaceuticals Business Overview
Table 111. WEX Pharmaceuticals Product
Table 112. WEX Pharmaceuticals Revenue in Cancer Pain Business (2015-2020) (US$ Million)
Table 113. WEX Pharmaceuticals Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Pain Market Share by Type: 2020 VS 2026
Figure 2. Opioids Features
Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 4. Others Features
Figure 5. Global Cancer Pain Market Share by Application: 2020 VS 2026
Figure 6. Paracetamol Treatment-Related Immunotherapy Case Studies
Figure 7. Radiotherapy Case Studies
Figure 8. Chemotherapy Case Studies
Figure 9. Hormone Therapy Case Studies
Figure 10. Cancer Pain Report Years Considered
Figure 11. Global Cancer Pain Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Cancer Pain Market Share by Regions: 2020 VS 2026
Figure 13. Global Cancer Pain Market Share by Regions (2021-2026)
Figure 14. Global Cancer Pain Market Share by Players in 2019
Figure 15. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Pain as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cancer Pain Revenue in 2019
Figure 17. North America Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Cancer Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. BioDelivery Science Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 45. ProStrakan Group Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 46. Teva pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 47. Eli-Lilly Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 48. Grunenthal Group Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 49. GW Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 50. JohnsonJohnson Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 51. Meda Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 52. Orexo Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 53. Sanofi Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 54. WEX Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3900
$ 5850

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top